Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Dave & Buster's
PLAY
$403M
| $3.07M | ﹤0.01% |
168,799
+16,525
| +11% | +$434K |
|
|
HTO
2527
H2O America
HTO
$2.56B
| $3.05M | ﹤0.01% |
62,704
-15,199
| -20% | -$759K |
|
|
PLYM
2528
DELISTED
Plymouth Industrial REIT
PLYM
| $3.05M | ﹤0.01% |
136,731
+48,588
| +55% | +$892K |
|
2529
MillerKnoll
MLKN
$1.64B
| $3.05M | ﹤0.01% |
171,940
-27,354
| -14% | -$554K |
|
2530
Rithm Capital
RITM
$5.62B
| $3.05M | ﹤0.01% |
267,341
-226,492
| -46% | -$2.74M |
|
2531
Omnicell
OMCL
$1.71B
| $3.04M | ﹤0.01% |
99,946
-312,624
| -76% | -$9.61M |
|
2532
Minerals Technologies
MTX
$2.33B
| $3.03M | ﹤0.01% |
48,808
-11,789
| -19% | -$719K |
|
2533
Ingevity
NGVT
$2.52B
| $3.03M | ﹤0.01% |
54,885
-18,878
| -26% | -$982K |
|
2534
United States Lime & Minerals
USLM
$3.21B
| $3.03M | ﹤0.01% |
23,004
-7,420
| -24% | -$857K |
|
2535
Eldorado Gold
EGO
$8.37B
| $3.02M | ﹤0.01% |
104,700
-45,502
| -30% | -$1.07M |
|
2536
CALL
Insmed
INSM
$21.3B
| $3.02M | ﹤0.01% |
+21,000
| New | +$2.57M |
|
|
2537
PUT
Insmed
INSM
$21.3B
| $3.02M | ﹤0.01% |
+21,000
| New | +$2.57M |
|
2538
Nabors Industries
NBR
$1.25B
| $3.02M | ﹤0.01% |
73,901
-3,018
| -4% | -$107K |
|
2539
AtriCure
ATRC
$1.97B
| $3.01M | ﹤0.01% |
85,478
-15,107
| -15% | -$521K |
|
|
VRNT
2540
DELISTED
Verint Systems
VRNT
| $3.01M | ﹤0.01% |
148,620
-62,481
| -30% | -$1.29M |
|
2541
Kulicke & Soffa
KLIC
$4.72B
| $3.01M | ﹤0.01% |
74,036
-28,490
| -28% | -$1.06M |
|
2542
CALL
Centrus Energy
LEU
$3.63B
| $3.01M | ﹤0.01% |
+9,700
| New | +$2.15M |
|
2543
World Kinect Corp
WKC
$2B
| $3.01M | ﹤0.01% |
115,805
-62,347
| -35% | -$1.68M |
|
|
SA
2544
Seabridge Gold
SA
$2.84B
| $3M | ﹤0.01% |
124,392
-13,674
| -10% | -$237K |
|
2545
Winmark
WINA
$1.25B
| $3M | ﹤0.01% |
6,033
-1,721
| -22% | -$739K |
|
2546
Northwest Natural Holdings
NWN
$2.06B
| $3M | ﹤0.01% |
66,822
-17,790
| -21% | -$738K |
|
2547
Community Trust Bancorp
CTBI
$1.43B
| $3M | ﹤0.01% |
53,570
-7,090
| -12% | -$398K |
|
2548
Monro
MNRO
$399M
| $3M | ﹤0.01% |
166,736
-12,404
| -7% | -$204K |
|
2549
PUT
Insulet
PODD
$11.8B
| $2.99M | ﹤0.01% |
9,700
+8,800
| +978% | +$2.76M |
|
2550
MDU Resources
MDU
$4.2B
| $2.99M | ﹤0.01% |
167,774
+76,467
| +84% | +$1.28M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.